• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过入院时多重耐药感染情况预测肝硬化急性失代偿患者的28天死亡率。

Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission.

作者信息

Gupta Tarana, Lochan Dibya, Verma Nipun, Rathi Sahaj, Agrawal Swastik, Duseja Ajay, Taneja Sunil, Chawla Yogesh K, Dhiman Radha K

机构信息

Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

出版信息

J Gastroenterol Hepatol. 2020 Mar;35(3):461-466. doi: 10.1111/jgh.14788. Epub 2019 Aug 29.

DOI:10.1111/jgh.14788
PMID:31334860
Abstract

BACKGROUND AND AIM

The aim of this study is to evaluate the epidemiology and impact of bacterial infections at admission in patients with acute decompensation (AD) of cirrhosis.

METHODS

A cohort with AD of cirrhosis (European Association for the Study of the Liver criteria) admitted at a tertiary center was evaluated between 2013 and 2014 for the presence of bacterial infections at admission. Clinical, demographic, and microbiological data were collected prospectively till death, transplant, or 90 days.

RESULTS

Of 179 patients with AD, 102 (56.9%) had bacterial infections at admission. The commonest infections were spontaneous bacterial peritonitis (SBP) (n = 65; 63.7%), spontaneous bacteremia (n = 10; 9.8%), pneumonia (n = 9; 8.8%), urinary tract infection (n = 8; 7.8%), spontaneous bacterial empyema (n = 4; 3.9%), and cellulitis (n = 2; 1.9%). The commonest source was community acquired (n = 85; 83.3%). Serum albumin and sodium levels were lower in infected as compared with non-infected cohort (P = 0.015; for both). Escherichia coli was the commonest organism isolated from SBP (n = 14; 21.5%), urinary tract infection (n = 5; 45.5%), and bacteremia (n = 3; 20%). There was a trend toward higher 28-day mortality in infected cohort as compared with non-infected cohort (48 [52.7%] vs 28 [32%]; P = 0.152). Multidrug-resistant organisms (MDROs) were isolated in 63% of all culture-positive infections. The presence of MDRO was an independent predictor of 28-day mortality.

CONCLUSIONS

Infections are the leading reason for the occurrence of AD; SBP is the most common infection, and E. coli is the commonest microorganism based on this single-center study of Indian patients with AD of cirrhosis. There is a high prevalence of MDROs among culture-positive infections that independently predict 28-day mortality in AD of cirrhosis.

摘要

背景与目的

本研究旨在评估肝硬化急性失代偿(AD)患者入院时细菌感染的流行病学情况及其影响。

方法

对2013年至2014年期间在一家三级中心收治的符合肝硬化AD(欧洲肝脏研究协会标准)的队列患者进行评估,以确定入院时是否存在细菌感染。前瞻性收集临床、人口统计学和微生物学数据,直至患者死亡、接受移植或90天。

结果

179例AD患者中,102例(56.9%)入院时存在细菌感染。最常见的感染是自发性细菌性腹膜炎(SBP)(n = 65;63.7%)、自发性菌血症(n = 10;9.8%)、肺炎(n = 9;8.8%)、尿路感染(n = 8;7.8%)、自发性细菌性脓胸(n = 4;3.9%)和蜂窝织炎(n = 2;1.9%)。最常见的感染源是社区获得性(n = 85;83.3%)。与未感染队列相比,感染队列的血清白蛋白和钠水平较低(两者P = 0.015)。大肠杆菌是从SBP(n = 14;21.5%)、尿路感染(n = 5;45.5%)和菌血症(n = 3;20%)中分离出的最常见病原体。与未感染队列相比,感染队列的28天死亡率有升高趋势(48例[52.7%]对28例[32%];P = 0.152)。在所有培养阳性感染中,63%分离出多重耐药菌(MDROs)。MDRO的存在是28天死亡率的独立预测因素。

结论

感染是AD发生的主要原因;基于对印度肝硬化AD患者的这项单中心研究,SBP是最常见的感染,大肠杆菌是最常见的微生物。培养阳性感染中MDRO的患病率很高,其独立预测肝硬化AD患者的28天死亡率。

相似文献

1
Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission.通过入院时多重耐药感染情况预测肝硬化急性失代偿患者的28天死亡率。
J Gastroenterol Hepatol. 2020 Mar;35(3):461-466. doi: 10.1111/jgh.14788. Epub 2019 Aug 29.
2
Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.肝硬化患者医院获得性自发性细菌性腹膜炎的临床意义及预后
Clin Infect Dis. 2009 May 1;48(9):1230-6. doi: 10.1086/597585.
3
Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital.一家三级转诊医院中肝硬化患者的多重耐药细菌感染
Gastroenterol Hepatol. 2019 Apr;42(4):228-238. doi: 10.1016/j.gastrohep.2018.07.017. Epub 2018 Oct 17.
4
Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.医疗相关及医院获得性自发性细菌性腹膜炎中的抗生素耐药性
Eur J Clin Invest. 2017 Jan;47(1):44-52. doi: 10.1111/eci.12701. Epub 2016 Dec 7.
5
Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections.肝硬化患者自发性细菌性腹膜炎的病原体和转归:社区获得性感染与医院获得性感染。
BMC Infect Dis. 2019 May 23;19(1):463. doi: 10.1186/s12879-019-4102-4.
6
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.二次感染独立增加肝硬化住院患者的死亡率:北美终末期肝病研究协会(NACSELD)的经验。
Hepatology. 2012 Dec;56(6):2328-35. doi: 10.1002/hep.25947.
7
Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications.肝硬化伴 SBP 患者:耐药菌增加和并发症。
Eur J Clin Invest. 2020 Feb;50(2):e13198. doi: 10.1111/eci.13198. Epub 2020 Jan 21.
8
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.欧洲失代偿期肝硬化和慢加急性肝衰竭患者中的多重耐药菌感染。
J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.
9
Microbiological profile of pathogens in spontaneous bacterial peritonitis secondary to liver cirrhosis: a retrospective study.肝硬化继发自发性细菌性腹膜炎病原体的微生物学特征:一项回顾性研究
Trop Doct. 2020 Apr;50(2):138-141. doi: 10.1177/0049475520905745. Epub 2020 Feb 18.
10
Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.肝硬化自发性细菌性腹膜炎患者中头孢曲松和喹诺酮类药物耐药的证据。
Dig Dis Sci. 2019 Aug;64(8):2359-2367. doi: 10.1007/s10620-019-05519-4. Epub 2019 Feb 14.

引用本文的文献

1
Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.中国肝硬化患者细菌感染的临床、微生物学及抗生素治疗特征:一项多中心研究
J Clin Transl Hepatol. 2025 Aug 28;13(8):644-654. doi: 10.14218/JCTH.2025.00211. Epub 2025 Jul 3.
2
Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with Cirrhosis: A Retrospective Case-Control Study.肝硬化患者内镜逆行胰胆管造影术后肝失代偿的预测因素:一项回顾性病例对照研究
Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071-2.
3
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.
肝硬化患者多重耐药菌感染的临床影响
Future Sci OA. 2024 May 14;10(1):FSO945. doi: 10.2144/fsoa-2023-0160. eCollection 2024.
4
Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT.特利加压素静脉输注与推注治疗慢性肝衰竭急性肾损伤患者的比较——一项开放标签随机对照试验
Clin Exp Hepatol. 2023 Dec;9(4):351-358. doi: 10.5114/ceh.2023.132813. Epub 2023 Dec 5.
5
Fecal Carriage of Multidrug-Resistant Organisms Increases the Risk of Hepatic Encephalopathy in Cirrhotic Patients: Insights from Gut Microbiota and Metabolite Features.多重耐药菌的粪便携带增加肝硬化患者肝性脑病风险:来自肠道微生物群和代谢物特征的见解
Res Sq. 2024 May 7:rs.3.rs-4328129. doi: 10.21203/rs.3.rs-4328129/v1.
6
Risk predict model using multi-drug resistant organism infection from Neuro-ICU patients: a retrospective cohort study.多药耐药菌感染神经重症监护病房患者的风险预测模型:一项回顾性队列研究。
Sci Rep. 2023 Sep 15;13(1):15282. doi: 10.1038/s41598-023-42522-2.
7
Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.印度急性肝衰竭患者细菌或真菌感染的患病率、危险因素及影响
Dig Dis Sci. 2023 Oct;68(10):4022-4038. doi: 10.1007/s10620-023-07971-9. Epub 2023 Aug 14.
8
Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis.肝硬化患者多部位多重耐药菌定植的负担、危险因素及结局
JHEP Rep. 2023 May 11;5(8):100788. doi: 10.1016/j.jhepr.2023.100788. eCollection 2023 Aug.
9
Spontaneous Bacterial Peritonitis: The Bug Matters.自发性细菌性腹膜炎:病原菌很关键。
Dig Dis Sci. 2023 May;68(5):1667-1669. doi: 10.1007/s10620-023-07865-w.
10
Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis.肝硬化感染相关性急性肾损伤患者28天死亡率的预测因素
World J Hepatol. 2022 Mar 27;14(3):592-601. doi: 10.4254/wjh.v14.i3.592.